chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My hips are killing me/I am having difficulty sleeping due to this; My hips are killing me/I am having difficulty sleeping due to this; I was not feeling comfortable; My back, knees and ankles were also hurting me; knees and ankles were also hurting me; This is a spontaneous report from a contactable nurse and a contactable physician. A male patient of an unspecified age receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was administered the second dose of Pfizer vaccine on Thursday. Unlike the first dose, the second one had adverse events. The patient stated, 'My hips are killing me, I am having difficulty sleeping due to this. I was not feeling comfortable. My back, knees and ankles were also hurting me' on an unspecified date. It was also stated that many of his colleagues had similar experiences. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.
This spontaneous report as received from a medical assistant refers to multiple patients of unknown demographics. On unknown dates the patients received improperly stored doses of VAQTA (lot # M015290 with expiry date: 20-SEP-2017). The temperature and timeframe that the VAQTA was exposed to were as follows: Temperature 50.4F. Timeframe: 19.5 hours total cumulative. The medical assistant reported that the patients received doses of improperly stored VAQTA but lot numbers and expiry dates of those specific vaccines that were administered was unknown. No adverse effects reported. Medical assistant also reported that the vaccines were not yet back in range. Data logger was involved. There were no previous excursions. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
3x3cm redness, no streaks, tender with palpation to right lateral thigh.  Reaction 24 hours post injection. Parent noticed about 19:30.  Treatment: Benadryl, Tylenol.
HYPONATREMIA; SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other manufacturer (pfizer) concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: rheumatoid arthritis, diabetes insipidus (since 2015), hypothyroidism, and unspecified drug allergy. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, 1 total administered on 30-OCT-2021 for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s. (dose number in series 1). The patient received non-company suspect moderna covid-19 vaccine (elasomeran) (dose number in series 2) (form of admin and route of admin were not reported batch number: 071F21A, expiry: UNKNOWN) dose was not reported, administered on 14-MAY-2022 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination moderna covid-19 vaccine (elasomeran) (dose number in series 2). The patient additionally received non-company suspect pfizer (tozinameran) (dose number in series 3) (form of admin and route of admin were not reported, batch number: UT7751KA, expiry: UNKNOWN) dose was not reported, administered on 30-SEP-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (dose number in series 3).  Concomitant medications included desmopressin, diphenhydramine, estradiol, guaifenesin, hydroxychloroquine, ibuprofen, levothyroxine, paracetamol, phenylephrine, and pseudoephedrine hydrochloride.  On an unspecified date in 2023, the patient experienced suspected covid-19 infection (dose number in series 3).  The patient administered non-company suspect drug (name unspecified) (form of admin, route of admin, batch number and expiry were not reported) dose was not reported, administered first dose on 02-OCT-2023 and last dose on 03-OCT-2023 for treatment of covid 19. On 03-OCT-2023 at 08:00, the patient experienced hyponatremia, and was hospitalized (date unspecified) (dose number in series 3). Duration of hospitalization was reported as 3 and discharge information were not reported. Laboratory data (dates unspecified) included: Blood test not reported. Treatment medications (dates unspecified) included: IV (intravenous) fluids, sodium tablet and fluid restricts. The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, and tozinameran was not applicable. The patient recovered from hyponatremia on 04-OCT-2023, and the outcome of suspected covid-19 infection and revaccination with different covid-19 vaccine was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20231013890-hyponatremia. The event shows an incompatible temporal relationship. Therefore, this event is considered inconsistent with vaccine administration.
vision being off; blurred vision; slight headache; This is a spontaneous report from a contactable consumer (patient). This 64-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the arm left on 20Jul2021 at 12:20 PM (Lot Number: EW0186) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included blood pressure (abnormal). Concomitant medications included atenolol with five years for blood pressure (abnormal), amlodipine besilate with five years for blood pressure (abnormal). On 20Jul2021, patient had vision was kind of off, slight headache. Patient received her first dose of the Pfizer BioNTech COVID-19 vaccine on 20Jul2021 at around 12:20pm. She started having blurred vision and slight headache at around 1:15-1:30. She would like to know if anyone else has reported these side effects. Patient stated that she will not get her second dose of the vaccine. Patient never got shots, never got the flu shot. Patient was fine in there but when she started looking at her phone, reading the email, her vision was kind of off. It was blurry a little bit. She had a slight headache. She didn't see that as a side effect. She didn't know if anyone else has had this reaction to the shot or not. Patient got the vaccine about 12:20PM. She had to wait 15 minutes so she got out of there about 12:50. She looked at her phone so maybe her vision being off and the headache started about 1:15PM or 1:30PM. It affected her when she looks at something she needs to read. Sees far fine. She had a headache and can tell when reading the article they gave her or her phone. She can't see that clear. Patient did not feel like she was having a medical emergency where she would need to call or go to the emergency room. Events did not require a visit to emergency room or physician office. No additional vaccines administered on same date of the Pfizer Suspect. No prior vaccinations (within 4 weeks). Outcome of the event blurred vision was unknown, while of the other events was not recovered.   No follow-up attempts are needed. No further information is expected.
Area around vaccine site red, approx 6 x 5 cm, mild TTP.
Shot given at 9am. The next am, L deltoid area was red, hot, swollen and hard. On 10/17/03 area is hard, swollen, red and has some broken blisters on surface that are weeping. Atarax for itch and Keflex given 10/18/03 per pediatrician.
Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Additional Details: Patient fainted and was unresponsive for about 2 minutes. We called 911 and they came to the store within 10 minutes. Pt blood pressure was normal when the paramedics arrived, blood sugar was checked and the value was 83. Patient was feeling better after about 30 minutes and the paramedics walked him to his car. His relative drove him home
severe headaches,   diffuculty swallowing,   pressure in throat,  pain in chest, back, neck, arms   treatment include visit to ED and hospitalized for 2 days.  multiple tests,  symptoms ongoing
Patient was waiting in chair about 2 minutes after he received his covid shot, said he felt dizzy. Tried to assist him but he had fainted and hit his head.
This is a 16 year old patient that received Moderna for her first dose of Covid vaccine instead of receiving Pfizer.  Per patients mother patient experienced body aches and flu like symptoms for 1 day after vaccine was administered and patient has been doing well since then.
Rash at injection site and swelling of lymph nodes in left armpit. Rash appeared 8 days post injection. Lymph node swelling occurred 4 days post injection and was most severe by day 8. Performed superficial massage to both areas as well as application of cold pack. Neither really helped. Symptoms resolved by day 12 post injection.
No adverse effects noted; expired dose was administered to one patient; This spontaneous report was received from a nurse and refers to a 12 month old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant therapies were not provided.   On 15-APR-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA ) intramuscularly, lot # R010369, expiration date 25-MAR-2019 (vaccination site and dose were not provided), for prophylaxis.
Fever (103.5 degrees F) 12 hours after vaccination. It lasted over +- 12 hours.
got the flu from the flu shot; Initial information received on 05-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involved a patient of unknown demographics who got the flu from the flu shot (Influenza), after receiving INFLUENZA VACCINE.   The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.    Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, the patient got the flu from the flu shot (Influenza) and he/she would never do that again.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the event was reported as unknown.  There will be no information available on the batch number for this case.
10/28/22 presents to ED for "suicidal" "cough and SOB for the past several days and was diagnosed with COVID-19 at an outside hospital". PMHx of "Bipolar mood disorder, ETOH abuse, GERD, HTN, Tobacco abuse, and Pancreatitis"
Treatment was standard to initially receiving the COVID-19 Pfizer-BioNTech two-dose vaccination back in March/April of 2021. I received the COVID vaccination first (between the two shots I was scheduled for). The shot was administered in my left arm, intramuscularly. Immediately afterwards, I received the Flublok Quadrivalent influenza vaccine in my right arm, intramuscularly. I developed some general discomfort about 8 hours after the appointment: some body chills and a headache was about it. By the following day, I noticed I had developed a pain in my left armpit area. I brushed it aside as some muscular pain from the COVID vaccination that I had received in that arm. Now nearly 48 hours later, I've physically checked the area and realized that there is an enlargement in my left armpit area that is causing the pain. The skin has raised in a circular shape between my armpit and nipple. It is painful to the touch -- I have to be gentle when lowering my left arm. It feels firm.. almost tumorous. As of the morning of November 15th, 2021, the enlargement still exists.
Rabavert given @ 1635 on 9-1-09.  At approx 2000 that evening that evening notice swelling in bilat hands and ankles.  Seen in clinic 9-2-09 at 1525 with complaints of swelling in hands and ankles and Rt ankle hurts.  Injection site in Rt Deltoid clean, dry and intact.  No redness or edema.
On 1/27/2021,  I woke up with a rash on my left arm where the shot was.  I called the insurance company for a telemedicine doctor as I do not have PCP.  I went to the store right afterwards o get a Benadryl cream.  The doctor called me in the afternoon.  by the time he contacted me the area had already began to heal.  The doctor looked and it and could see that it was red and bumpy, he prescribed prednisone, I did not pick up the RX because it was healing and I did not think I needed.  The doctor was not certain if the rash was caused by my allergy of bandage glue or the vaccine. It cleared up a day and a half.
Patient who is 13 years old inadvertently administered COVID Moderna Vaccine on the left deltoid at 3:50 pm on 04/04/22. This was patient first COVID Vaccine.  Patient informed as well as the PCP.
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 6-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
I had surgery for Hyperhyrdrosis in 2006.  It basically ended my immense sweating.  Since receiving this Pfizer vaccination it has come back very strong.  Its all over my body.  I told the doctors before i received the vaccine that I had this problem in the past
Fever (100.4) 24 hours after injection, severe headache starting two hours after injection, joint ache, muscle ache, fatigue, chills, sore throat (starting 6 hours after injection)  Took advil 8 hours after injection; plan to take another dose of advil.
Dizziness; numb tongue; difficulty swallowing; difficulty breathing; inability to move arms and legs; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EN6199 and expiration date unknown), via an unspecified route of administration in the left arm on 09Mar2021 at 15:00 as a single dose for COVID-19 immunization. Medical history included depression, pre-diabetes and known allergies: bee stings. Concomitant medications included loratadine (LORATADINE), metformin (METFORMIN), paroxetine (PAROXETINE), and bupropion hydrochloride (WELLBUTRIN), and "Mul". The patient had no other vaccine in four weeks. On 09Mar2021 at 15:15, The patient experienced dizziness, numb tongue, difficulty swallowing, difficulty breathing, and inability to move arms and legs. The patient had no COVID prior vaccination and had not tested post vaccination. Therapeutic measures were taken as a result of the events which included Epinephrine, ER treatment, and Prednisone. The outcome of the events was resolving. The events resulted in: Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event).
Pt vaccinated w/1st does on 14NOV89, 2nd dose on 14DEC89 & 3rd dose on 17MAY90 developed hives 17MAY90 tx @ Hosp & recovered;
Pt. received the Flu vaccine (flulaval) on 12/29/2020 and started having symptoms on 12/30/2020. Dizziness, lightheadedness, fatigue, muscle pain, weakness headaches, chills (no fever)
From phone contact with reporting MD, it was stated that a 67 y.o. female PT received a TD adult vaccination on 7/16/01. Reportedly on 7/19/01, the PT complained of non-specific symptoms in her left leg. All she relayed to the physician was it didn't feel right and wasn't working the way she wanted. PT was doing housework at the time. No neurological or vascular deficits on exam. Asymptomatic 7/20/01. PT has past medical history of spinal condition. Physician feels it is related to that condition. Prescribed Ibuprofen 400mg 4 times a day.
Pt developed total body rash evening of vaccine. Pt not seen Dr the rash in office.
This spontaneous report was received from a medical assistant concerning to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On an unknown date the patients were vaccinated with unspecified doses of improperly stored ROTATEQ oral liquid, lot # K022995 expiration date 22-JUL-2016, or lot # L008574 expiration date 22-NOV-2015; (dose and dose number were unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pts granddaughter says she was not feeling well and a couple of weeks after taking the vax and had to call 911 on 4/16/2021. Paramedics took her to Hospital ER, in same city and state as patient, where she was admitted.  She called her granddaughter 4/18/2021 and told her she had tested positive for Covid Virus while at the hospital and that she had a blood clot on her lung.  She is being treated w/ a blood thinner.
1. Appendicitis: developed after 5 days, still early with low white blood cell count, followed by laparascopic appendectomy 2. Arm rash and soreness developed after 6 days at the vaccination location (left arm), with redness at the arm and swelling and pain of the arm.
rash on lower leg for first day.  Headache, decrease appetite and nausea for second day.
Approximately one week after receiving one dose of varicella virus vaccine live the pt developed generalized chickenpox. The number of lesions was unspecified.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 9:05 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 9:05 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 61.66.   Concomitant products were not provided.  On 13-FEB-2021, Excursion time was reported at 9:00 A.M with  temperature as 32 degrees Fahrenheit, total doses given for the day was 152, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 9-FEB-2021, vial was moved to clinic on 13-JAN-2021. 30 vials were sent to clinic. Vaccine BUD date was  10-MAR-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).